Solution: Federal And State Policy

In The News John Coster Discusses Drug Pricing Executive Order in STAT

ADVI Experts Lindsay Greenleaf and Mary Roberts Share Insight Ahead of #AXS25
Events ADVI Health is Attending Asembia’s AXS25 Summit
In The News Lindsay Bealor Greenleaf Joins Managed Healthcare Executive’s Webinar Discussing Healthcare in the Early Days of the Second Trump Administration
In The News ADVI Health Welcomes Policy Veteran John Coster

Insights,

ADVI Analysis: HRSA 340B Covered Entity Audits

Case Study: Rare Disease State Policy Engagement
ADVI Angle Vertical

Insights,

| Allison Schneider, MHA - Director

Prescription Drug Affordability Boards: Access Concerns and Implications for Rare Diseases and Conditions
In The News Lindsay Bealor Greenleaf Included in Medtech Dive